feb 2, 2010

Viroblock SA hires Dr. Jamie Paterson as CEO
and Closes Financing Round

Viroblock SA, a start-up dedicated to developing and commercializing a new generation of anti-viral products, today announced that Dr. Jamie Paterson will join Viroblock as Chief Executive Officer (CEO)...
» learn more

JUNE 2, 2009

Un spray pour mieux lutter contre la grippe

Article paru dans le journal Le Temps...
» learn more

MaY 5, 2009

Viroblock SA Reports a 99% Boost of Efficacy of Facemasks against H5N1

Viroblock SA announces that its antiviral products boosts the efficacy of facemasks by at least 99.0%, i.e. 100 times better and a peak performance of 1000 times, against avian influenza virus H5N1...
» learn more

Mar 31, 2009

Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray

Viroblock SA has announced today that the first generation of VCCD Tech antiviral nasal spray formulation is active against human influenza...
» learn more

Jan 2, 2008

Preventing the Influenza virus

Viroblock has started the first series of experiments to validate its antiviral approach against Influenza virus. Initial in vitro assays will be followed by a series of animal testing using the ferret model...
» learn more

Jul 19, 2007

First round of funding

Viroblock SA, a start-up dedicated to developing and commercializing a new generation of antiviral products, today announced that it has completed its first round of equity funding...
» learn more